BMI >30 kg/m 2 or Waist hip ratio>0.9 for men, >0.85 for women. 2) TG e"150 mg/dl or HDL <35 mg/dl (male), <39 mg/dl (female). 3). BP e"140/90 mm Hg or on medication.
Fifty million Americans now carry the diagnosis of metabolic syndrome a cluster of life shortening morbidities that include type 2 diabetes. 2 Prevalence of metabolic syndrome is extremely high among young adults in urban areas and the most prevalent components of the metabolic syndrome are found to be high triglycerides, low HDL cholesterol, high blood pressure, abdominal obesity and high fasting glucose respectively. 3 The prevalence of metabolic syndrome in developed countries is 22-39%. 1 The prevalence of type 2 diabetes was found to be 3.8% in rural Bangladesh among subjects in the age category 30-64 years (Hussain et al. 2006 ). The prevalence of metabolic syndrome in rural Bangladesh is <3%. 4 Diabetes mellitus is the commonest metabolic abnormality in the world. Type 2 diabetes is the commonest form of diabetes, constituting nearly 90% of diabetic population in any country. Prevalence of type 2 diabetes is increasing in most of the countries especially in developing countries. 5 The metabolic syndrome has been shown to be predictive of cardiovascular diseases (CVD) and diabetes. Diabetic patients are at an excessive risk of CVD mortality. In addition to increasing the risk of CVD, the metabolic syndrome may hasten the development of stroke and complication of diabetes mellitus like diabetic nephropathy, retinopathy and neuropathy. 6 The metabolic syndrome prevalence is even higher in diabetes mellitus patients and insulin resistance is believed to be the underlying cause for both type 2 diabetes mellitus and the metabolic syndrome.
Patients with type-2 diabetes mellitus (DM) already fulfill one of the NCEP-ATP III or IDF diagnostic criteria, and two more are required for metabolic syndrome diagnosis. From an epidemiological point of view, the syndrome is highly prevalent in patients with type-2 DM, and it often precedes the onset of hyperglycemia. The prevalence of the metabolic syndrome is 46.9% for males and 65.1% for females in Korea with type 2 diabetes mellitus. 7 However, much controversy surrounds the importance of Metabolic Syndrome in diabetics as a separate biological entity over each of its components as a cardiovascular risk factor. On the other hand, many studies have shown that Metabolic Syndrome, irrespective of its definition, is an independent clinical indicator of macrovascular and microvascular complications in diabetics. 8 We studied the prevalence of metabolic syndrome in our newly diagnosed type 2 diabetes mellitus patients. So that we can aware the diabetic patients as well as concerned physicians about the prevalence of metabolic syndrome so that adequate measures may be taken to reduce the risk of cardiovascular disease.
Materials and Methods:
It was a cross sectional study. 
Anthropometric Measurements
Body weight (in kg) was measured in light clothing and without shoes. The weight was recorded to the nearest kg. Height was measured without shoes with the subjects standing fully erect on a flat surface and taken to the nearest centimeter. Body mass index was calculated by the formula -BMI = Weight in kg / (Height in meter) 2 Waist circumference (in centimeter) was measured at midway between the costal margin & iliac crest. Waist circumference was measured at the end of normal expiration.
Hip circumference (in centimeter) was taken as the largest circumference at the posterior extension of the buttocks (Transtrochantaric). Waist hip ratio is the waist circumference divided by the hip circumference.
Blood pressure was measured on the right arm in the sitting position using a sphygmomanometer by the auscultatory method.
Diagnosis of Type 2 Diabetes Mellitus
Type 2 diabetes mellitus was diagnosed by history and performing blood glucose level. Fasting e" 126 mg/dl or 2 hours after oral glucose load is e" 200 mg/dl was considered diagnostic of diabetes mellitus. 9 
Laboratory Analysis
From each subject 5ml fasting venous blood sample was drawn by a disposable plastic syringe with all aseptic precautions in sitting posture and was collected into a properly cleaned and dry test tube without any anticoagulant. 
Results and Observations:
A total of two hundred newly diagnosed type 2 diabetes mellitus patients were included in this study. . Out of all patients maximum 35.0% were within 41 to 50 years age group followed by 24.0% within 31 to 40 years, 25.0% within 51 to 60 years, 9.5% within 20 to 30 years and 6.5% more than 60 years age group ( Figure-1 ). Among study subjects 117 (58.5%) were male and 83 (41.5%) % were female. Male and female ratio was 1.43: 1. Prevalence of metabolic syndrome among study subjects by sex was shown in Table- 8 metabolic syndrome in females was also found significantly more than in males. On the other hand Ford et al found that prevalence of metabolic syndrome were more common in male. 18 Considerable prevalence of metabolic syndrome in type 2 diabetes mellitus patients is alarming in our population. Sedentary life style, altered food habits and obesity may be responsible for this.
Fig 1: Age distribution of the patients

Conclusion:
From this study it may be concluded that prevalence of metabolic syndrome is considerable in newly diagnosed type 2 diabetic patients in our population. So both diabetic patients & physicians should be aware of the prevalence of metabolic syndrome. The considerable prevalence of metabolic syndrome in our population is implicative of an alarming risk of cardiovascular disease in future.
Recommendations:
1. Physicians treating type-2 diabetics should consider metabolic syndrome with greater emphasis and manage the patients accordingly.
2. Studies with larger samples may be conducted to define more precisely the frequency of metabolic syndrome and its different components among diabetics and non-diabetic subjects.
3. Prospective follow up studies are needed to identify the impact of metabolic syndrome on long-term complications of DM.
